Overview


According to FutureWise analysis the market for placenta in 2023 is US$ 85.88 million, and is expected to reach US$ 222.24 million by 2031 at a CAGR of 12.60%.

The placenta, which is arguably the most important organ of the body, is often overlooked. The outcome of the pregnancy and the mother's life after it is over for her, as well as the health of her child, are determined by the placenta. A healthy placenta can be a benefit to the child's mental, metabolic, cardiovascular and other health functions. This vital organ is not well understood. New initiatives are focusing on placental health and the outcomes thereof. The placenta is becoming a culturally significant object for many people, including researchers, clinicians and biobanks. These diverse constituencies could be at odds. The placenta develops and grows alongside the baby during pregnancy. This organ, which is a disk-shaped shape, acts as a barrier between maternal and fetal blood circulation. The placenta is responsible for releasing important chemical messengers known as hormones throughout pregnancy.

Hormones inform the mother that there is a pregnancy ongoing and instruct it on how to provide nutrients for the growing baby. Hormones are vital to a healthy body, as pop culture and internet science repeatedly remind us. The placenta's tree-like protrusions are deeply embedded in the mother's womb and allow selectively the transfer of nutrients, oxygen, and waste products. The placenta is capable of filtering compounds that could have adversely affected pregnancy, such as stress signals. My research focuses on the ability of placental cells to communicate with the mother's womb. They disengage themselves from the tree-like protrusions of the placenta and invade the mother's womb in a cancer-like fashion to make it work for them. They are announcing their presence in the body. The placental cells communicate directly with the immune cells to protect the mother's fetus from being mislabeled as an "invader". They can also be rejected by or attacked by the resident immune systems. These adaptations are vital to the health of both mother and baby throughout pregnancy and into the future. Postpartum parents and their families may want to take back their placenta. Third parties, however, can use the placentas for research, medical and commercial purposes. We often think of childbirth as the beginning and end of labor. Although we rarely think about what happens after the baby is born and what the "third stage" of labor is, anyone who is familiar with childbearing will know that this is the time when the placenta is delivered or afterbirth. The placenta is typically delivered 15 to 30 minutes after the baby. Often ignored or treated as a waste product to be discarded, the placenta is typically not the focus of attention among parents,maternity-care professionals, or legal scholars. The social life of the placentas doesn't begin with pregnancy. Some placentas are killed by healthcare facilities. Others are buried, planted, or transformed into art. Still, others are used for research or banked.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Placenta Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Placenta Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Japan Bio Products Co. Ltd
  • CJT
  • BIOON
  • Japan Natural Laboratories Co. Ltd
  • Brooklyn Placenta Services LLC
  • MiMedx Group Inc.
  • Atlanta Placenta
  • Telagen
  • Thimba Li
  • Agri-Lab Co-Products

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Porcine
  • Equine
  • Ovine
  • Others

By Application

  • Pharmaceuticals
  • Cosmetics
  • Supplements
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Placenta Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Placenta Market Variables, Trends and Scope
    •         1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Placenta Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Placenta Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Placenta Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Porcine
        2. Equine
        3. Ovine
        4. Others

  • 8.   Placenta Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceuticals
        2. Cosmetics
        3. Supplements
        4. Others

  • 9.   North America Placenta Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Placenta Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Placenta Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Placenta Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Japan Bio Products Co. Ltd
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. CJT
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. BIOON
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Japan Natural Laboratories Co. Ltd
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Brooklyn Placenta Services LLC
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. MiMedx Group Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Atlanta Placenta
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Telagen
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Thimba Li
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Agri-Lab Co-Products
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients